Gilead Sciences, Inc.
GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)
Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%
Gilead Sciences Operating cash flow by Year
Operating cash flow (Form 8-K Selected Cash Flow Information, $M) ($M)
Gilead Sciences Operating cash flow: $10,019M in FY2025, down 7.5% from a year earlier.
Latest, FY2025
10,019
Period ended Dec 31, 2025
Change on a year earlier
-7.5%
10,828 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below
Where the FY2025 figure comes from
“|| Net cash provided by operating activities | $ | 3,326 | $ | 2,975 | $ | 10,019 | $ | 10,828”
Source: Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗
Reported in Form 8-K Selected Cash Flow Information.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Operating cash flow (Form 8-K Selected Cash Flow Information, $M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10,019 | -7.5% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2024 | Dec 31, 2024 | 10,828 | +35.2% | Form 8-K (exhibit991earningspressrel.htm, filed 2026-02-10) ↗ |
| FY2023 | Dec 31, 2023 | 8,006 | -11.8% | Form 8-K (exhibit991earningspressrel.htm, filed 2025-02-11) ↗ |
| FY2022 | Dec 31, 2022 | 9,072 | -20.3% | Form 8-K (exhibit991earningspressrel.htm, filed 2024-02-06) ↗ |
| FY2021 | Dec 31, 2021 | 11,384 | +39.4% | Form 8-K (exhibit991earningspressrel.htm, filed 2023-02-02) ↗ |
| FY2020 | Dec 31, 2020 | 8,168 | – | Form 8-K (exhibit991earningspressrel.htm, filed 2022-02-01) ↗ |
Cite this data
StockData. (2026). Gilead Sciences Operating cash flow ($M), annual FY2020–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rel-ocf-row
See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.